GCS 3000Dx



Hu Y., et al. Genotyping performance between saliva and blood- derived genomic DNAs on the DMET array: a comparison. PLoS One, 7(3): e33968 (2012).
Burmester J. K., et al. DMET microarray technology for pharmacogenomics-based personalized medicine. Methods in Molecular Biology 632:99-124 (2010).
Sissung T. M., et al. Clinical pharmacology and pharmacogenetics in a genomics era: the DMET platform. Pharmacogenomics 11(1):89-103 (2010).
Bridget Bradley B., et al. Developing an interdisciplinary pharmacogenomic treatment approach to reduce medication burden and improve subject outcomes. Journal of Pharmacy Practice [College of Psychiatric and Neurologic Pharmacists 2011 Poster Abstracts] 24: 268-269 (2011).
Stack C.B., et al. Genetic risk estimation in the Coriell Personalized Medicine Collaborative. Genetics in Medicine 13(2):131-139 (2011).
Man M., et al. Genetic variation in metabolizing enzyme and transporter genes: Comprehensive assessment in 3 major East Asian subpopulations with comparison to Caucasians and Africans. Journal of Clinical Pharmacology 50(8): 929-940 (2010).
UNC's McCleod discusses 'practical' approach to bringing pharmacogenetics to all countries. GenomeWeb Pharmacogenomics Reporter (2010).
Affymetrix, Inc. Coriell Institiute for Medical Research selects Affymetrix DMETTM Plus Product for national personalized medicine project. Press release (2009).


DMET™ Plus


シスメックス株式会社 LS事業本部 LS営業部
Tel:03-5434-8569(東京) 078-992-7221(神戸)